Browse > Article
http://dx.doi.org/10.5734/JGM.2011.8.2.105

Communication with Family Members about Positive BRCA1/2 Genetic Test Results in Korean Hereditary Breast Cancer Families  

Kang, Eun-Young (Department of Surgery, Seoul National University Bundang Hospital)
Park, Sue-K. (Department of Preventive Medicine, Seoul National University College of Medicine)
Kim, Ku-Sang (Department of Surgery, Ajou University School of Medicine)
Choi, Doo-Ho (Department of Radiation Oncology, Sungkyunkwan University School of Medicine)
Nam, Seok-Jin (Department of Surgery, Sungkyunkwan University School of Medicine)
Paik, Nam-Sun (Department of Surgery, Ewha Womans' University Medical Center)
Lee, Jong-Won (Department of Surgery, Asan Medical Center, College of Medicine, University of Ulsan)
Lee, Min-Hyuk (Department of Surgery, Soonchunhyang University Hospital)
Kim, Sung-Won (Department of Surgery, Seoul National University Bundang Hospital)
Publication Information
Journal of Genetic Medicine / v.8, no.2, 2011 , pp. 105-112 More about this Journal
Abstract
Purpose: Sharing genetic information with family members is important for cancer awareness and prevention. The purpose of this study is to examine disclosure patterns of positive BRCA genetic test results to patients' relatives. Materials and Methods: A total of 106 probands who had positive BRCA genetic test results from the Korean Hereditary Breast Cancer Study participated in our study. Subjects were asked whether they had disclosed their genetic test results to first-, second-, and third-degree relatives. Univariate and multivariate analyses were used to identify factors associated with positive result sharing with close and distant relatives. Results: In total, 99 respondents (93.4%) informed at least one at-risk relative of the test result, and they all reported that they had disclosed their genetic test result to a first-degree relative. Communication of test results to other relatives occurred significantly less often, with only 31 of 99 subjects (31.3%) sharing their results with second- or third-degree relatives. In the results of univariate analyses, disclosure of genetic test results to more distant relatives was associated with marital status and months since post-test counseling. The reasons for communication were to provide information about the BRCArelated cancer risk and to recommend the genetic test. Conclusion: Most individuals with the BRCA mutation share their test results with first-degree family members; however, these results reach more distant relatives significantly less often. Therefore, it is necessary to encourage patients' communication with extended family members through systematic genetic counseling.
Keywords
BRCA1/2 mutation; Communication; Genetic counseling;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med 2003;348:2339-47.   DOI   ScienceOn
2 Pasacreta JV. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest 2003;21:588-623.   DOI   ScienceOn
3 van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden Duivenvoorden HJ, van Gool AR, Seynaeve C, et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003;21:3867-74.
4 Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 2008;10:19-32.   DOI   ScienceOn
5 Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72: 1117-30.   DOI   ScienceOn
6 Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22.
7 Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997:87-92.
8 Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84.   DOI   ScienceOn
9 Kim EK, Kim KS, Park SK, Ahn SH, Lee MH, Kim SW, et al. The Korean Hereditary Breast Cancer (KOHBRA) Study: protocol rewiew. J Breast Cancer 2007;10:241-7.   DOI   ScienceOn
10 Kang E, Ahn SH, Noh WC, Noh DY, Jung YS, Kim LS, et al. The KOHBAR Study has changed the practive patterns for managing hereditary breast cancer in Korea. J Breast Cancer 2010;13:351-6.
11 Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 2006;24:700-6.   DOI   ScienceOn
12 Green MJ, Peterson SK, Baker MW, Harper GR, Friedman LC, Rubinstein WS, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA 2004;292:442-52.   DOI   ScienceOn
13 Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008;6:333-8.   DOI   ScienceOn
14 Han SA, Park SK, Ahn SH, Son BH, Lee MH, Choi DH, et al. The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report. J Breast Cancer 2009;12:92-9.   DOI
15 Han SA, Park SK, Ahn SH, Lee MH, Noh DY, Kim LS, et al. The Korean Hereditary Breast Cancer (KOHBRA) Study: Protocols and Interim Report. Clin Oncol 2011;23: 434-41.   DOI   ScienceOn
16 Foster C, Evans DG, Eeles R, Eccles D, Ashley S, Brooks L, et al. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Test 2004;8:23-9.   DOI   ScienceOn
17 McGivern B, Everett J, Yager GG, Baumiller RC, Hafertepen A, Saal HM. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 2004;6:503- 9.   DOI   ScienceOn
18 Kim KS, Kim SW, Lee MH, Ahn SH, Park SK, Korean Breast Cancer Society. Practice patterns of surgeons for the management of hereditary breast cancer in Korea. J Breast Cancer 2008;11:95-101.   DOI   ScienceOn
19 Garber JE, Patenaude AF. Ethical, social and counselling issues in hereditary cancer susceptibility. Cancer Surv 1995;25:381-97.
20 Julian-Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Nogues C, et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 1996;33:731-6.   DOI
21 American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21: 2397-406.   DOI   ScienceOn
22 Hughes CH, Lynch H, Durham C, Snyder C, Lemon S, Narod S, et al. Communication of BRCA1/2 test results in hereditary breast cancer families. Cancer Res Ther Control 1999;8:51-9.
23 Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 2003;116A:11-9.   DOI
24 McGivern B, Everett J, Yoger GG, Baumiller RC, Hafertepen A, Saal HM. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 2004;6:503- 9.   DOI   ScienceOn